Chilton Capital Management LLC Bristol Myers Squibb CO Transaction History

Chilton Capital Management LLC

$2.25 Billion
Q1 2025

A detailed history of Chilton Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chilton Capital Management LLC holds 22,811 shares of BMY stock, worth $1.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

22,811

Previous 24,482 6.83%

Holding current value

$1.07 Million

Previous $1.38 Million 0.51%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	SELL	$53.9 - $63.11 $90,066 - $105,456	-1,671 Reduced 6.83%	22,811 $1.39 Million
Q4 2024 Feb 07, 2025	SELL	$51.92 - $59.94 $176,528 - $203,796	-3,400 Reduced 12.19%	24,482 $1.38 Million
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $2,052 - $2,702	51 Added 0.18%	27,882 $1.16 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $47,932 - $54,345	-999 Reduced 3.47%	27,831 $1.51 Million
Q4 2023 Jan 18, 2024	BUY	$48.48 - $57.85 $177,921 - $212,309	3,670 Added 14.59%	28,830 $1.48 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $17,367 - $19,419	-300 Reduced 1.18%	25,160 $1.46 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $103,164 - $117,012	-1,570 Reduced 5.81%	25,460 $1.76 Million
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $48,945 - $53,906	674 Added 2.56%	27,030 $2.08 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $14,078 - $16,881	229 Added 0.88%	26,356 $1.93 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $11,047 - $12,879	206 Added 0.79%	26,127 $1.63 Million
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $562,115 - $658,445	-9,500 Reduced 26.82%	25,921 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1.36 Million - $1.49 Million	22,031 Added 164.53%	35,421 $2.37 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $20,769 - $23,359	-350 Reduced 2.55%	13,390 $845,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $16,240 - $23,600	-350 Reduced 2.48%	13,740 $766,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $73,815 - $96,285	-1,500 Reduced 9.62%	14,090 $904,000
Q3 2019 Nov 15, 2019	BUY	$42.77 - $50.71 $125,914 - $149,290	2,944 Added 23.28%	15,590 $791,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $564,264 - $623,953	12,646 New	12,646 $573,000

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.

Account

Chilton Capital Management LLC Bristol Myers Squibb CO Transaction History